Paper7259802
The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications.
Bengtsson BA and 1 other. Arthritis Rheum, 1981. Cited by 254 papers, by iCite.
Cite this record
ConductScience Library. The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications. Papers, record 7259802. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7259802
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Eye Diseases | Major topic |
| Giant Cell Arteritis | Major topic |
| Polymyalgia Rheumatica | Major topic |
| Blindness | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Sweden |
Source PubMed
Cited by49
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 254 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42871723 | Ocular Manifestations and Visual Outcomes of Patients with Giant Cell Arteritis. | J Ophthalmol Adv Res | 2026 | https://conductscience.org/library/papers/42871723 | PubMed |
| 41572017 | Prevalence of diplopia among giant cell arteritis patients: a systematic review and meta-analysis. | Eye (Lond) | 2026 | https://conductscience.org/library/papers/41572017 | PubMed |
| 40689118 | Neuro-ophthalmic Manifestations of Giant Cell Arteritis: A Review. | J Ophthalmic Vis Res | 2025 | https://conductscience.org/library/papers/40689118 | PubMed |
| 38933754 | Predictive Factors for Biopsy-Negative Giant Cell Arteritis and Alternative Diagnoses in a Neuro-Ophthalmology Context. | Neuroophthalmology | 2024 | https://conductscience.org/library/papers/38933754 | PubMed |
| 38478104 | Predominance of T-bet-positive Th1 cells in infiltrating T-lymphocytes in most of active arteritis lesions of giant cell arteritis. | Virchows Arch | 2025 | https://conductscience.org/library/papers/38478104 | PubMed |
| 37197804 | Frequency of visual involvement in a 10-year interdisciplinary cohort of patients with giant cell arteritis. | Clin Med (Lond) | 2023 | https://conductscience.org/library/papers/37197804 | PubMed |
| 36556036 | Predictive Factors of Giant Cell Arteritis in Polymyalgia Rheumatica Patients. | J Clin Med | 2022 | https://conductscience.org/library/papers/36556036 | PubMed |
| 36057073 | Giant Cell Arteritis: A Case-Based Narrative Review of the Literature. | Curr Pain Headache Rep | 2022 | https://conductscience.org/library/papers/36057073 | PubMed |
| 34853411 | Global epidemiology of vasculitis. | Nat Rev Rheumatol | 2022 | https://conductscience.org/library/papers/34853411 | PubMed |
| 34513351 | Retinal Detachment and Temporal Artery Dissection: An Elusive Case of Giant Cell Arteritis. | Cureus | 2021 | https://conductscience.org/library/papers/34513351 | PubMed |
| 34011407 | Assessment of the efficacy and safety of tocilizumab in patients over 80 years old with giant cell arteritis. | Arthritis Res Ther | 2021 | https://conductscience.org/library/papers/34011407 | PubMed |
| 33067687 | Morbidity and Mortality of Large-Vessel Vasculitides. | Curr Rheumatol Rep | 2020 | https://conductscience.org/library/papers/33067687 | PubMed |
| 31440812 | Characteristics of patients with giant cell arteritis who experience visual symptoms. | Rheumatol Int | 2019 | https://conductscience.org/library/papers/31440812 | PubMed |
| 31286712 | Arteritic Anterior Ischemic Optic Neuropathy Associated with Giant-Cell Arteritis in Korean Patients: A Retrospective Single-Center Analysis and Review of the Literature. | J Clin Neurol | 2019 | https://conductscience.org/library/papers/31286712 | PubMed |
| 30458857 | Comorbidities in polymyalgia rheumatica: a systematic review. | Arthritis Res Ther | 2018 | https://conductscience.org/library/papers/30458857 | PubMed |
| 29443189 | Temporal arteritis. | Neurol Clin Pract | 2014 | https://conductscience.org/library/papers/29443189 | PubMed |
| 29246164 | Incidence of giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study. | Arthritis Res Ther | 2017 | https://conductscience.org/library/papers/29246164 | PubMed |
| 29051823 | Giant cell aortitis leading to Stanford type B and type A aortic dissection. | JRSM Open | 2017 | https://conductscience.org/library/papers/29051823 | PubMed |
| 27297405 | Evaluating the Incidence of Arteritic Ischemic Optic Neuropathy and Other Causes of Vision Loss from Giant Cell Arteritis. | Ophthalmology | 2016 | https://conductscience.org/library/papers/27297405 | PubMed |
| 25512481 | Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohort. | J Rheumatol | 2015 | https://conductscience.org/library/papers/25512481 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7259802
GET https://conductscience.org/api/papers/v1/7259802/cited_by?page=2